title: [Antimetastatic effects of UFT on murine liver metastasis model using L5178YHM lymphoma].
authors.affiliation: Second Cancer Research Laboratory, Taiho Pharmaceutical Co., Ltd.
authors.forename: H
authors.initials: H
authors.lastname: Satake
authors.forename: T
authors.initials: T
authors.lastname: Takechi
authors.forename: K
authors.initials: K
authors.lastname: Nakano
authors.forename: H
authors.initials: H
authors.lastname: Saito
authors.forename: J
authors.initials: J
authors.lastname: Uchida
authors.forename: S
authors.initials: S
authors.lastname: Takeda
authors.forename: N
authors.initials: N
authors.lastname: Unemi
authors.forename: M
authors.initials: M
authors.lastname: Fukushima
mesh_terms: D000818:Animals; D001835:Body Weight / Q000187:drug effects; D004338:Drug Combinations; D005467:Floxuridine / Q000008:administration & dosage; D007940:Leukemia L5178 / Q000188:drug therapy* / Q000473:pathology*; D008113:Liver Neoplasms / Q000517:prevention & control* / Q000556:secondary*; D008297:Male; D051379:Mice; D005641:Tegafur / Q000008:administration & dosage; D014498:Uracil / Q000008:administration & dosage
chemical_list: D004338:Drug Combinations; C096910:UFT(R) drug; D005467:Floxuridine; D005641:Tegafur; D014498:Uracil; C025034:doxifluridine